{"doi":"10.1002/adhm.202101467","title":"<i>β</i> ‐Catenin Limits Osteogenesis on Regenerative Materials in a Stiffness‐Dependent Manner","abstract":"Targeted refinement of regenerative materials requires mechanistic understanding of cell-material interactions. The nanoparticulate mineralized collagen glycosaminoglycan (MC-GAG) scaffold is shown to promote skull regeneration in vivo without additive exogenous growth factors or progenitor cells, suggesting potential for clinical translation. This work evaluates modulation of MC-GAG stiffness on canonical Wnt (cWnt) signaling. Primary human bone marrow-derived mesenchymal stem cells (hMSCs) are differentiated on two MC-GAG scaffolds (noncrosslinked, NX-MC, 0.3 kPa vs conventionally crosslinked, MC, 3.9 kPa). hMSCs increase expression of activated β-catenin, the major cWnt intracellular mediator, and the mechanosensitive YAP protein with near complete subcellular colocalization on stiffer MC scaffolds. Overall Wnt pathway inhibition reduces activated β-catenin and osteogenic differentiation, while elevating BMP4 and phosphorylated Smad1/5 (p-Smad1/5) expression on MC, but not NX-MC. Unlike Wnt pathway downregulation, isolated canonical Wnt inhibition with β-catenin knockdown increases osteogenic differentiation and mineralization specifically on the stiffer MC. β-catenin knockdown also increases p-Smad1/5, Runx2, and BMP4 expression only on the stiffer MC material. Thus, while stiffness-induced activation of the Wnt and mechanotransduction pathways promotes osteogenesis on MC-GAG, activated β-catenin is a limiting agent and may serve as a useful target or readout for optimal modulation of stiffness in skeletal regenerative materials.","journal":"Advanced Healthcare Materials","year":2021,"id":174821,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":23,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9583,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2021-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":714512,"name":"Xiaoyan Ren","orcid":"0000-0002-0622-7412","position":1,"is_corresponding":false},{"id":714513,"name":"Michelle K. Oberoi","orcid":"0000-0003-0993-489X","position":2,"is_corresponding":false},{"id":267051,"name":"Meiwand Bedar","orcid":"0000-0003-1747-6665","position":3,"is_corresponding":false},{"id":714952,"name":"Rachel M. Caprini","orcid":null,"position":4,"is_corresponding":false},{"id":351303,"name":"Marley J. Dewey","orcid":"0000-0001-6074-7139","position":5,"is_corresponding":false},{"id":714514,"name":"Vasiliki Kolliopoulos","orcid":"0000-0001-5567-6620","position":6,"is_corresponding":false},{"id":714953,"name":"Dean T. Yamaguchi","orcid":null,"position":7,"is_corresponding":false},{"id":337214,"name":"Brendan A.C. Harley","orcid":"0000-0001-5458-154X","position":8,"is_corresponding":false},{"id":336613,"name":"Justine C. Lee","orcid":"0000-0002-8943-0837","position":9,"is_corresponding":false},{"id":714511,"name":"Qi Zhou","orcid":"0000-0002-4963-5897","position":0,"is_corresponding":true}],"reference_count":39,"raw_metadata":null,"created_at":"2026-07-18T23:47:06.584146Z","pmid":"34585526","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}